CO-FOUNDER, PRESIDENT & CEO

Business development and commercialization executive in biologics with over 25 years in the Neuroscience space, with Allergan, Biogen and Merz Neurosciences.

CO-FOUNDER & CHIEF SCIENTIFIC OFFICER

Accomplished scientific leader in antibody and VHH/nanobody therapeutic development with senior roles at Pfizer, Bristol Myers Squibb, and Denali Therapeutics, where she led antibody discovery for CNS targets.

Professor Emeritus at the Vrije Universiteit Brussel (VUB), is internationally recognized for discovering the heavy-chain-only antibody system in camelids and for co-inventing the Nanobody® platform that led to the creation of Ablynx

SCIENTIFIC ADVISOR

One of Germany’s foremost neuroscientists. Professor of Neurobiology at Braunschweig Technical University and head of the Neuroinflammation and Neurodegeneration research group at the Helmholtz Centre for Infection Research in Braunschweig.

SCIENTIFIC ADVISOR

31 years of Biotech development experience with a proven track record of developing revolutionary and pivotal therapies